Fatigue News and Research

RSS

Complementary, alternative therapies for heart failure have some benefits and potential risks

There are some benefits and potentially serious risks when people with heart failure use complementary and alternative medicines (CAM), to manage symptoms, so involving the health care team is important for safety, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 Dec 2022

COVID‑19 infection in early 2020 associated with subsequent poorer mental health

Those who reported having COVID in early 2020 were also 1.67 times more likely to display clinically meaningful levels of anxiety after 13 months, than those who avoided COVID-19 in the same time period.

8 Dec 2022

COVID-19 vaccines may reduce long-COVID symptoms

A new study describes the effectiveness of coronavirus disease 2019 (COVID-19) vaccines in reducing long-COVID symptoms.

8 Dec 2022

Adult females exhibit impaired muscle and pulmonary function after COVID-19 recovery

In a new study, researchers examined muscle and pulmonary dysfunction during moderate exercise in adult females who recovered from coronavirus disease 2019 (COVID-19).

8 Dec 2022

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole and 63 percent in combination with anastrozole, according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

Many studies have described a variety of long-term effects of COVID-19, with symptoms including fatigue and malaise, breathing difficulties, and cognitive problems, often referred to as post COVID-19 condition or long COVID.

7 Dec 2022

Research extends the powerful tool of immunotherapy to autoimmune diseases

The cancer therapy known as CAR-T has revolutionized treatment of some blood cancers since it was introduced in 2017. The therapy uses genetically altered immune cells to home in on cancer cells and destroy them.

6 Dec 2022

Study provide new insights into why cholestasis causes cognitive issues

Patients with cholestatic liver disease such as primary biliary cholangitis (PBC) can experience significant impairment of bile flow and may develop neurological symptoms including fatigue and cognitive decline.

6 Dec 2022

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

The Pfizer-BioNTech mRNA-based COVID-19 vaccine may increase the risk of menstrual disturbances in adolescent girls in their first cycle after vaccination.

6 Dec 2022

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

Researchers investigated the clinical, histopathological, imaging, and serological characteristics of post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) in patients with mild COVID-19.

5 Dec 2022

Long Covid symptoms experienced by children and young people change over time, study finds

The Children and young people with Long Covid (CLoCk) study, published in The Lancet Regional Health – Europe, is the world's largest study on long Covid in children.

5 Dec 2022

SARS-CoV-2 Omicron infections pose long-COVID risks despite reduced severity

researchers compared the post-coronavirus disease complaints and symptoms in individuals infected with the SARS-CoV-2 Omicron variant with those in individuals with Delta variant infections to understand whether the long-term complaints after Omicron infections are similar to those in infections with other SARS-CoV-2 variants.

2 Dec 2022

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

The impact of Pfizer‐BioNTech’s BNT162b2 mRNA vaccine booster on the maximum oxygen uptake capacity among recreational endurance athletes

Researchers evaluated the impact of Pfizer‐BioNTech’s BNT162b2 mRNA vaccine booster on the maximum oxygen uptake capacity (VO2max) among recreational endurance athletes.

29 Nov 2022

Fatigue News and Research

Complementary, alternative therapies for heart failure have some benefits and potential risks

COVID‑19 infection in early 2020 associated with subsequent poorer mental health

COVID-19 vaccines may reduce long-COVID symptoms

Adult females exhibit impaired muscle and pulmonary function after COVID-19 recovery

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

Research extends the powerful tool of immunotherapy to autoimmune diseases

Study provide new insights into why cholestasis causes cognitive issues

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

Long Covid symptoms experienced by children and young people change over time, study finds

SARS-CoV-2 Omicron infections pose long-COVID risks despite reduced severity

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

Women having a higher BMI more likely to experience long Covid

New evidence of mpox virus transmission before onset of symptoms

Broccoli and sprouts improve gut microbiota and reduce inflammation in IBD

Monkeypox renamed "mpox" in an effort to combat stigma

COVID-19 pandemic fatigue in Hong Kong

Photon-counting CT may help to effectively identify post-COVID patients at risk for lung damage

The impact of Pfizer‐BioNTech’s BNT162b2 mRNA vaccine booster on the maximum oxygen uptake capacity among recreational endurance athletes

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News